About this market
Technavio's needle-free drug delivery devices market analysis considers sales from inhalers, transdermal patches, and jet injectors. Our study also finds the sales of needle-free drug delivery devices in Asia, Europe, North America, and ROW. In 2019, the inhalers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high incidence of asthma will play a significant role in the inhalers segment to maintain its market position. Also, our global needle-free drug delivery devices market report looks at factors such as the increasing prevalence of chronic disease, rising number of new product launches, and the growing number of strategic alliances. However, frequent product recalls, stringent regulations associated with drug-device combination products, and high costs associated with needle-free drug delivery devices may hamper the growth of the needle-free drug delivery devices industry over the forecast period.
Increasing prevalence of chronic diseases
Chronic diseases such as diabetes, especially type 1 diabetes is on the rise. According to the OECD, in 2017, about 600 children per 100,000 children had type 1 diabetes in Finland. With growing pollution and respiratory infections, instances of asthma have also dramatically increased. Physicians use needle-free drug delivery devices to administer insulin to children with type 1 diabetes. These devices also prove to be quite effective in the immediate administration of asthmatic medications. Needle-free drug delivery devices administer drugs through the skin of patients either by using shock waves or as a pressure generated by gas or electrophoresis. With the increasing prevalence of various chronic diseases such as diabetes and asthma, the need for needle-free drug delivery devices is increasing, which will lead to the expansion of the global needle-free drug delivery devices market at a CAGR of over 4% during the forecast period.
Technological advances in needle-free drug delivery devices
The intense competition in the market is compelling vendors to invest in R&D to expand their product portfolios. They are developing innovative and advanced devices to administer regular medications for disease management. These devices facilitate the process of drug administration for the management of several diseases and health conditions. The integration of software with needle-free drug delivery devices helps patients to adhere to their regular regimen of medication and, at the same, allows physicians to analyze the condition of their patients and improve the management of chronic respiratory diseases, such as asthma. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global needle-free drug delivery devices market during the forecast period 2020-2024, view our report.
With the presence of several major players, the global needle-free drug delivery devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading needle-free drug delivery devices manufacturers, that include 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.
Also, the needle-free drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
TABLE OF CONTENTS
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Inhalers - Market size and forecast 2019-2024
- Transdermal patches - Market size and forecast 2019-2024
- Jet injectors - Market size and forecast 2019-2024
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Technological advances in needle-free drug delivery devices
- Research and funding for development of needle-free drug delivery devices
- Increasing government initiatives
PART 12: VENDOR LANDSCAPE
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- 3M Co.
- Antares Pharma Inc.
- Becton, Dickinson and Co.
- Enesi Pharma Ltd.
- GlaxoSmithKline Plc
- Inovio Pharmaceuticals Inc.
- Mylan NV
- Novartis AG
- PharmaJet Inc.
- Valeritas Holdings Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO